The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes

Clinical trial NCT06376240 · COMPLETED

Trial details

NCT number: NCT06376240
Sponsor: Maastricht University Medical Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 2 Diabetes Microvascular Function Retinopathy, Diabetic Nephropathy, Diabetic Neuropathy, Diabetic

Start date: 2024-03-21
Primary completion: 2026-03-13
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.